Cargando…

Effect of Prophylactic Palivizumab on Admission Due to Respiratory Syncytial Virus Infection in Former Very Low Birth Weight Infants with Bronchopulmonary Dysplasia

The aim of this study was to observe the effects of prophylactic palivizumab on hospitalization secondary to respiratory syncytial virus (RSV) infection (RSVhospitalization) in former very low birth weight infants (VLBWI) with bronchopulmonary dysplasia (BPD). This study also sought to identify the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Young Mi, Seo, Hyun Joo, Choi, Seo Heui, Jung, Yu Jin, Ahn, So Yoon, Yoo, Hye Soo, Sung, Se In, Shim, Jae Won, Lee, Yeon Kyung, Ko, Sun Young, Shin, Son Moon, Hwang, Jong Hee, Lee, Jang Hoon, Choi, Byung Min, Kim, Eun Sun, Jeon, Ji Hyun, Kim, Sung Shin, Chang, Yun Sil, Park, Won Soon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479947/ https://www.ncbi.nlm.nih.gov/pubmed/26130956 http://dx.doi.org/10.3346/jkms.2015.30.7.924

Ejemplares similares

Erratum: Effect of Prophylactic Palivizumab on Admission Due to Respiratory Syncytial Virus Infection in Former Very Low Birth Weight Infants with Bronchopulmonary Dysplasia
Publicado: (2016)

Outcomes of Palivizumab Prophylaxis for Respiratory Syncytial Virus Infection in Preterm Children with Bronchopulmonary Dysplasia at a Single Hospital in Korea from 2005 to 2009
por: Chang, Seung Gu, et al.
Publicado: (2010)

Strategies to improve outcomes of bronchopulmonary dysplasia
por: Jung, Young Hwa, et al.
Publicado: (2019)

Incidence of Bronchopulmonary Dysplasia in Korea
por: Choi, Chang Won, et al.
Publicado: (2012)

The efficacy and safety of Montelukast sodium in the prevention of bronchopulmonary dysplasia
por: Kim, Sang Bum, et al.
Publicado: (2015)

Protective effect of chorioamnionitis on the development of bronchopulmonary dysplasia triggered by postnatal systemic inflammation in neonatal rats
por: Choi, Chang Won, et al.
Publicado: (2016)

Early pulmonary hypertension is a risk factor for bronchopulmonary dysplasia-associated late pulmonary hypertension in extremely preterm infants
por: Kim, Hyun Ho, et al.
Publicado: (2021)

Increased cytotoxic T-cells in the airways of adults with former bronchopulmonary dysplasia
por: Um-Bergström, Petra, et al.
Publicado: (2022)

Differences in Comorbidities and Clinical Burden of Severe Bronchopulmonary Dysplasia Based on Disease Severity
por: Kim, Hye-Rim, et al.
Publicado: (2021)

The protective effect of CXC chemokine receptor 2 antagonist on experimental bronchopulmonary dysplasia induced by postnatal systemic inflammation
por: Lee, Seung Hyun, et al.
Publicado: (2020)

Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial
por: Ahn, So Yoon, et al.
Publicado: (2021)

Recent Changes in the Incidence of Bronchopulmonary Dysplasia among Very-Low-Birth-Weight Infants in Korea
por: Jo, Heui Seung, et al.
Publicado: (2015)

Chorioamnionitis: Is a major player in the development of bronchopulmonary dysplasia?
por: Choi, Chang Won
Publicado: (2017)

Respiratory severity score as a predictive factor for severe bronchopulmonary dysplasia or death in extremely preterm infants
por: Jung, Young Hwa, et al.
Publicado: (2019)

Interstitial pneumonia pattern on day 7 chest radiograph predicts bronchopulmonary dysplasia in preterm infants
por: Kim, Hye-Rim, et al.
Publicado: (2017)

Correction to: Respiratory severity score as a predictive factor for severe bronchopulmonary dysplasia or death in extremely preterm infants
por: Jung, Young Hwa, et al.
Publicado: (2019)

Trends in Survival and Incidence of Bronchopulmonary Dysplasia in Extremely Preterm Infants at 23–26 Weeks Gestation
por: Kim, Jin Kyu, et al.
Publicado: (2016)

Stem Cell Therapy for Bronchopulmonary Dysplasia: Bench to Bedside Translation
por: Ahn, So Yoon, et al.
Publicado: (2015)

Impact of the definition of bronchopulmonary dysplasia on neurodevelopmental outcomes
por: Han, Yea-Seul, et al.
Publicado: (2021)

Respiratory syncytial virus and palivizumab prophylaxis in the COVID-19 era
por: Taylor, Richard S.
Publicado: (2021)

Comparison of definitions of bronchopulmonary dysplasia to reflect the long-term outcomes of extremely preterm infants
por: Jeon, Ga Won, et al.
Publicado: (2022)

Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Restores Alveolar and Pulmonary Vascular Development in a Rat Model of Bronchopulmonary Dysplasia
por: Lee, Hyun Ju, et al.
Publicado: (2014)

Association of newer definitions of bronchopulmonary dysplasia with pulmonary hypertension and long-term outcomes
por: Hwang, Jae Kyoon, et al.
Publicado: (2023)

Deferoxamine Improves Alveolar and Pulmonary Vascular Development by Upregulating Hypoxia-inducible Factor-1α in a Rat Model of Bronchopulmonary Dysplasia
por: Choi, Chang Won, et al.
Publicado: (2015)

Respiratory-syncytial virus immunoprophylaxis on asthma symptoms development in prematurity with bronchopulmonary dysplasia
por: Fang, Li-Ching, et al.
Publicado: (2023)

Bronchopulmonary Dysplasia: New High Resolution Computed Tomography Scoring System and Correlation between the High Resolution Computed Tomography Score and Clinical Severity
por: Shin, Su-Mi, et al.
Publicado: (2013)

The Association of Pregnancy-induced Hypertension with Bronchopulmonary Dysplasia – A Retrospective Study Based on the Korean Neonatal Network database
por: Shin, Seung Hyun, et al.
Publicado: (2020)

Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)
por: Bollani, Lina, et al.
Publicado: (2015)

Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value
por: Olchanski, Natalia, et al.
Publicado: (2018)

Clinical Utility of Echocardiography for Early and Late Pulmonary Hypertension in Preterm Infants: Relation with Bronchopulmonary Dysplasia
por: Seo, Yo Han, et al.
Publicado: (2017)

Outcomes of infants with severe bronchopulmonary dysplasia in the pediatric intensive care unit
por: Choi, Yu Hyeon, et al.
Publicado: (2021)

Definitions of bronchopulmonary dysplasia and long-term outcomes of extremely preterm infants in Korean Neonatal Network
por: Jeon, Ga Won, et al.
Publicado: (2021)

Effect of respiratory syncytial virus infection on regulated on activation, normal T-cells expressed and secreted production in a murine model of asthma
por: Ju, Yanghua, et al.
Publicado: (2011)

Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia
por: An, Hyo Soon, et al.
Publicado: (2010)

Delayed diagnosis of allergic bronchopulmonary aspergillosis due to absence of asthmatic symptoms
por: Kim, Young, et al.
Publicado: (2016)

Aerosol Delivery of Palivizumab in a Neonatal Lamb Model of Respiratory Syncytial Virus Infection
por: Edirisinghe, Hasindu S., et al.
Publicado: (2023)

Right Atrial Strain in Preterm Infants With a History of Bronchopulmonary Dysplasia
por: Kang, Soo Jung, et al.
Publicado: (2022)

Association between vitamin D deficiency at one month of age and bronchopulmonary dysplasia
por: Byun, Shin Yun, et al.
Publicado: (2021)

Two Cases of Bronchopulmonary Dysplasia of Similar Appearance in Adult Monozygotic Twin: Pathology and Computed Tomographic Findings
por: Lee, Yoon Pyo, et al.
Publicado: (2015)

Bronchoconstriction following instillation of phenylephrine eye drops in premature infants with bronchopulmonary dysplasia: two cases report
por: Kim, Hyun Jee, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tmil1er42k3h32h3hokh86htuq